Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the SPDR FactSet Innovative Technology ETF (XITK), we found that the implied analyst target price for the ETF based upon its underlying holdings is $69.93 per unit.

START SLIDESHOW:
10 ETFs With Most Upside To Analyst Targets »

With XITK trading at a recent price near $62.40 per unit, that means that analysts see 12.06% upside for this ETF looking through to the average analyst targets of the underlying holdings. Three of XITK's underlying holdings with notable upside to their analyst target prices are Allscripts Healthcare Solutions, Inc. ( MDRX), Rubicon Project Inc ( RUBI), and Groupon Inc ( GRPN). Although MDRX has traded at a recent price of $11.27/share, the average analyst target is 34.30% higher at $15.14/share. Similarly, RUBI has 34.04% upside from the recent share price of $7.74 if the average analyst target price of $10.38/share is reached, and analysts on average are expecting GRPN to reach a target price of $4.96/share, which is 24.24% above the recent price of $3.99. Below is a twelve month price history chart comparing the stock performance of MDRX, RUBI, and GRPN:

MDRX, RUBI, and GRPN Relative Performance Chart

Below is a summary table of the current analyst target prices discussed above:

Name Symbol Recent Price Avg. Analyst 12-Mo. Target % Upside to Target
SPDR FactSet Innovative Technology ETF XITK $62.40 $69.93 12.06%
Allscripts Healthcare Solutions, Inc. MDRX $11.27 $15.14 34.30%
Rubicon Project Inc RUBI $7.74 $10.38 34.04%
Groupon Inc GRPN $3.99 $4.96 24.24%

Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now? Do the analysts have a valid justification for their targets, or are they behind the curve on recent company and industry developments? A high price target relative to a stock's trading price can reflect optimism about the future, but can also be a precursor to target price downgrades if the targets were a relic of the past. These are questions that require further investor research.

The average analyst target price data upon which this article was based, is courtesy of data provided by Zacks Investment Research via Quandl.com.
Get the latest Zacks research report on MDRX — FREE
Get the latest Zacks research report on RUBI — FREE
Get the latest Zacks research report on GRPN — FREE

More from Stocks

Jim Cramer: The Market Refs Are Gone, and Flash Crashes Will Keep Happening

Jim Cramer: The Market Refs Are Gone, and Flash Crashes Will Keep Happening

Does Davos Matter Anymore? Why Jim Cramer Says It Will Play Less of a Role

Does Davos Matter Anymore? Why Jim Cramer Says It Will Play Less of a Role

Investing Is a 'Constant Learning Game' According to M1 Finance CEO

Investing Is a 'Constant Learning Game' According to M1 Finance CEO

IBM, Procter & Gamble, Ford, Comcast and Mariano Rivera - 5 Things You Must Know

IBM, Procter & Gamble, Ford, Comcast and Mariano Rivera - 5 Things You Must Know

US Stock Futures Gain Despite Trade Concerns; Oil Rises on China Stimulus Hopes

US Stock Futures Gain Despite Trade Concerns; Oil Rises on China Stimulus Hopes